Table 2.
VL management practices: observation of doctor patient consultations.
| India | Nepal | Bangladesh | Overall | |||||
|---|---|---|---|---|---|---|---|---|
| 2009 | 2010 | 2009 | 2010 | 2009 | 2010 | 2009 | 2010 | |
| No. of doctor-patient consultations observed: 1st visit | (n = 23) | (n = 23) | (n = 3) | (n = 12) | (n = 5) | (n = 18) | (n = 31) | (n = 53) |
| Follow-up visit | (n = 13) | (n = 0) | (n = 0) | (n = 0) | (n = 17) | (n = 20) | (n = 30) | (n = 20) |
|
| ||||||||
| (i) Doctor asked patient for family h/o VL at 1st visit | 13/23 (57%) |
11/23 (48%) |
3/3 (100%) |
9/12 (75%) |
5/5 (100%) |
18/18 (100%) |
21/31 (68%) |
38/53 (72%) |
| (ii) Doctor asked about pregnancy at 1st visit of women of reproductive age | 5/7 (71%) |
6/6 (100%) |
— | 1/6 (17%) |
1/1 (100%) |
— | 6/8 (75%) |
7/12 (58%) |
| (iii) Doctor advised drug dose based on patient's weight at 1st visit | 22/23 (96%) |
23/23 (100%) |
3/3 (100%) |
10/12 (83%) |
5/5 (100%) |
18/18 (100%) |
30/31 (97%) |
51/53 (96%) |
| (iv) Temperature of patient was measured | 23/36 (64%) |
23/23 (100%) |
3/3 (100%) |
5/12 (42%) |
5/22 (23%) |
18/38 (47%) |
31/61 (51%) |
46/73 (63%) |
| (v) Doctor examined patient for spleen enlargement | 23/36 (64%) |
23/23 (100%) |
3/3 (100%) |
12/12 (100%) |
5/22 (23%) |
18/38 (47%) |
31/61 (51%) |
53/73 (73%) |
| (vi) Doctor advised blood tests for patient | 21/36 (58%) |
20/23 (87%) |
3/3 (100%) |
5/12 (42%) |
3/22 (14%) |
12/38 (32%) |
27/61 (44%) |
37/73 (51%) |
| (vii) On FU visit, doctor asked patient for side effects | 13/13 (100%) |
— | — | — | 1/17 (6%) |
19/20 (95%) |
14/30 (47%) |
19/20 (95%) |